Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Sarcoma & GIST 2014 Conference

Four hundred attendees are expected from throughout Europe and elsewhere. An international faculty, including some of the most respected and pioneering experts dealing with these rare cancers, has developed the conference programme.

Download the Sarcoma & GIST 2014 Programme

Who should attend?

  • medical oncologists
  • surgeons
  • radiation therapists
  • gynecologists
  • pathologists
  • molecular biologists

who are involved with the research and treatment of soft tissue sarcomas and GIST.

Major themes

  • Gastrointestinal sarcoma (GIST) – Sensitive disease
  • Gastrointestinal sarcoma (GIST) – Resistant disease
  • Desmoid tumours
  • Soft tissue sarcomas: Localised disease
  • Molecularly-targeted soft tissue sarcomas
  • Personalised treatment for soft tissue sarcomas
  • Uterine sarcoma
  • Issues in some neglected types of sarcomas
  • How to study sarcomas

Benefits in attending:

This conference aims to provide a comprehensive overview of current medical therapy for soft tissue sarcomas and GIST, with a focus on personalised clinical approach from a multidisciplinary aspect and the molecular and pathological bases of these diseases. With this goal, lectures on molecular biology and those on treatment will be grouped together in the same sessions. These will be based on the various anatomical regions from which sarcomas can arise throughout the body, thus going from the classical limb locations to retroperitoneum, from visceral (including GIST) to gynaecological, thoracic, muscles, peripheral nerves, vascular primary sites. How the next-generation sequencing will change the current landscape, as well as topics on emerging targets and new drugs are incorporated into main sessions. The audience will take home an updated overview of where do we currently stand with personalising the treatment for soft tissue sarcomas and GIST and where we are going to, thanks to a top-level faculty, incorporating the major clinical and translational experts from the worldwide sarcoma community.

Learning objectives:

  1. To understand and learn some histological and molecular aspects of soft tissue sarcomas and GIST which are relevant for clinical practice
  2. To understand the implications of a multidisciplinary approach in the management of soft tissue sarcomas and GIST
  3. To present an update on how to personalise the current state-of-the-art management of soft tissue sarcoma and GIST, which will be approached comprehensively according to the anatomic site of origin

CME accreditation

The programme of this event will be:

  • Accredited with ESMO-MORA category 1 points
  • Submitted for CME accreditation to the EACCME (Accreditation Council for Continuing Medical Education). EACCME is an institution of the European Union of Medical Specialists (UEMS). These credits are also recognised by the American Medical Association (AMA) as Physician’s Recognition Award (AMA PRA Category 1 credits)


There will be no abstract submission for this meeting.


The conference webcasts will include all the session of the official programme, where speaker permission is granted ,and will be available on this website and OncologyPRO for ESMO members.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.